Leerink Partnrs Has Positive Forecast for REGN Q1 Earnings
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) – Stock analysts at Leerink Partnrs upped their Q1 2025 earnings per share (EPS) estimates for Regeneron Pharmaceuticals in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst D. Risinger now forecasts that the biopharmaceutical company will earn $7.56 per share for the quarter, up from […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) – Stock analysts at Leerink Partnrs upped their Q1 2025 earnings per share (EPS) estimates for Regeneron Pharmaceuticals in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst D. Risinger now forecasts that the biopharmaceutical company will earn $7.56 per share for the quarter, up from […]
